Using the Miltenyi CliniMACS Prodigy system, a GMP-compliant platform capable of cell selection and expansion in a closed system, we selected 1 x 108 CD4+ and CD8+ cells from a single NSCLC pleural effusion. This evidence concerns the gene CD8A and non-small cell lung carcinoma.